The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas

The influence of combretastatin A-4 disodium phosphate (CA-4, 50 mg/kg intraperitoneally (i.p.)) and vinblastine (2 mg/kg i.p.) on interstitial fluid pressure (IFP) was assessed in BT4An rat gliomas implanted subcutaneously in the neck. Furthermore the growth inhibitory effect of vinblastine and the distribution of fluorescence-conjugated vinblastine (BODIPY-vinblastine) were investigated. Tumors at different volumes were compared. Whereas CA-4 had no major influence on IFP, independent of tumor size, vinblastine increased the IFP in neoplasms above 8 cm3 (P=0.03). Vinblastine yielded a significant tumor response only in tumors below 2.1 cm3 (P=0.03). The distribution of BODIPY-vinblastine was heterogeneous and comparable despite tumor volume differences. We conclude that the influence of vinblastine on IFP is more pronounced than that of CA-4 in BT4An neck tumors, and that vinblastine may reduce subsequent drug delivery to solid tumors by increasing the IFP.